Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson Wang

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
JAMA|May 28, 2026
Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-AnalysisNelson Wang, Stephen Van Der Hoorn, Rashmi Pant, et al.
Lancet (London, England)|August 30, 2025
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trialsNelson Wang, Abdul Salam, Rashmi Pant, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2024
Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET TrialNelson Wang, Amy Von Huben, Simone Marschner, et al.
JAMA Cardiology|April 13, 2022
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical TrialSonali R Gnanenthiran, Nelson Wang, Gian Luca Di Tanna, et al.
American Journal of Preventive Cardiology|July 3, 2026
Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohortNelson Wang, Deepak L Bhatt, Constance Xhaard, et al.
Nature Medicine|October 10, 2022
Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof studyChristian Razo, Catherine A Welgan, Catherine O Johnson, et al.
Journal of Neurointerventional Surgery|October 7, 2018
Direct endovascular thrombectomy and bridging strategies for acute ischemic stroke: a network meta-analysisKevin Phan, Adam A Dmytriw, Declan Lloyd, et al.
Journal of the American College of Cardiology|September 1, 2024
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
Nature Medicine|October 10, 2022
The Burden of Proof studies: assessing the evidence of riskPeng Zheng, Ashkan Afshin, Stan Biryukov, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
JAMA|May 28, 2026
Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-AnalysisNelson Wang, Stephen Van Der Hoorn, Rashmi Pant, et al.
Lancet (London, England)|August 30, 2025
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trialsNelson Wang, Abdul Salam, Rashmi Pant, et al.
Hypertension (Dallas, Tex. : 1979)|March 13, 2024
Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET TrialNelson Wang, Amy Von Huben, Simone Marschner, et al.
JAMA Cardiology|April 13, 2022
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical TrialSonali R Gnanenthiran, Nelson Wang, Gian Luca Di Tanna, et al.
American Journal of Preventive Cardiology|July 3, 2026
Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohortNelson Wang, Deepak L Bhatt, Constance Xhaard, et al.
Nature Medicine|October 10, 2022
Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof studyChristian Razo, Catherine A Welgan, Catherine O Johnson, et al.
Journal of Neurointerventional Surgery|October 7, 2018
Direct endovascular thrombectomy and bridging strategies for acute ischemic stroke: a network meta-analysisKevin Phan, Adam A Dmytriw, Declan Lloyd, et al.
Journal of the American College of Cardiology|September 1, 2024
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
Nature Medicine|October 10, 2022
The Burden of Proof studies: assessing the evidence of riskPeng Zheng, Ashkan Afshin, Stan Biryukov, et al.
Pageof 8